Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Ranking of 20 Drug Companies Shows Sales Force Effectiveness Reaching Plateau
- A ranking of 20 drug companies by sales and marketing productivity shows that 10 companies saw upward trends in effectiveness in Q2 2009. Last quarter, 13 companies had upward trends. The numbers indicate that companies have started to reach a plateau in their efforts to wring more revenues out of...
- Blog posts 2009-08-07
- Ranking of 20 Drug Companies by Sales Force Effectiveness Shows Improvement in Q1
- A ranking of 20 drug companies on sales and marketing productivity shows upward trends in effectiveness in Q1 2009. At the top of the table is AIDS drug specialist Gilead. At the bottom of the table is vanity pharma play Medicis. by Jim Edwards
- Blog posts 2009-05-14
- Wyeth v. Levine's Unintended Consequences: Prescription Data-Mining Banned in Vermont
- A federal court in Vermont has upheld a law preventing drug companies from "data-mining" prescription information from pharmacies. The court cited the U.S. Supreme Court's Wyeth v. Levine anti-preemption ruling as one of its reasons in doing so, suggesting that the Wyeth decision will consequences far beyond personal injury class-actions....
- Blog posts 2009-04-27
- Pharma Roundup: Schering-Plough Surveys Investors, Wyeth Defended, and More
- Schering-Plough shareholders to have say on executive compensation, U.S. drug sales predictions lowered, McCain and Obama both promise hard line on Big Pharma. Also: two lawyers condemn unfounded anti-Wyeth opinions. by John Maas
- Blog posts 2008-10-29
- Academic Drug Conflicts Probe: "Problems With Transparency Are Everywhere"
- Emory. Harvard. Stanford. Brown. The University of Texas. The University of Cincinnati. It's a roll call of the nation's most prominent schools of psychiatry. But top researchers and professors at those schools could, essentially, be rented out by drug companies for hundreds of thousands of dollars. Then, those academics allegedly...
- Blog posts 2008-10-03
Additional Resources
- J&J and Risperdal: New Claims of Kickbacks and Fraudulent Marketing
- The news on Risperdal continues to get worse for Johnson & Johnson and its antipsychotic unit, Janssen Pharmaceuticals. Texas officials filed suit against the company alleging Medicaid fraud, kickbacks and improper marketing of the drug to children and the poor in that state. J&J denies the claims. ...
- Blog posts 2008-12-17
- Open Biosystems Appoints Ray "Woody" Woodward Vice President of Sales and Marketing
- Seasoned Medical Device Sales and Marketing Leader to Enhance Brand of Cutting-Edge Drug Discovery Tools HUNTSVILLE, Ala. -- Open Biosystems, Inc., focused on the commercialization of leading-edge life science research tools for drug discovery, today announced the appointment of Ray E. "Woody" Woodward as Vice President of Sales and...
- Research articles 2006-11-02
- FDA Expands Use of Convera Search Technology for Drug Review and Approval Process
- VIENNA, Va. -- Convera (NASDAQ:CNVR), a leading provider of search and categorization software for enterprises and government agencies, today announced expanded use of the company's RetrievalWare search technology by approximately 2,500 scientific review staff within the Center for Drug Evaluation and Research CDER at the FDA. The FDA's CDER uses...
- Research articles 2004-06-22
- FDA to Allow "Off-Label" Unapproved Drug Promotion
- The FDA has "finalized" guidelines allowing drug companies to promote drugs for unapproved ("off-label") uses. The guidelines will allow companies to distribute peer-reviewed scientific literature discussing off-label uses. Drug companies and their right-wing stalking horse, the Washington Legal Foundation, have been pushing for this move for years....
- Blog posts 2009-01-13
- Pfizer to Pay $2.3 Billion in Fraudulent-Marketing Suit
- NEW YORK (AdAge.com) -- Pharmaceutical giant Pfizer agreed today to pay $2.3 billion to settle the largest fraudulent-health-care-marketing case in the history of the Department of Justice. The settlement stems from government charges that Pfizer falsely marketed and promoted four of its drugs -- pain medication Bextra, anti-epilepsy drug Lyrica,...
- News items 2009-09-02
- Report: Company-funded studies of Pfizer epilepsy drug misleading | News from The Post-Standard -
- Report: Company-funded studies of Pfizer epilepsy drug misleading By The Associated Press November 11, 2009, 8:16PM Mark Lennihan / The Associated Press, 2009The Pfizer world headquarters in New York. Analysis of a dozen published studies testing possible new uses for a Pfizer Inc. epilepsy drug...
- News items 2009-11-11
- Bayer Urges India to Link Patents and Drug Approvals to Stymie Generics Producers
- Bayer has placed itself at the forefront of an international lobbying campaign by the pharmaceutical industry to link patents and marketing approval in foreign countries. On Monday, the Delhi High Court will hear a case in which Bayer wants a ruling that will legally link marketing approval for drugs to...
- Blog posts 2009-01-20
- FDA to Allow "Off-Label" Unapproved Drug Promotion
- The FDA has "finalized" guidelines allowing drug companies to promote drugs for unapproved ("off-label") uses. The guidelines will allow companies to distribute peer-reviewed scientific literature discussing off-label uses. Drug companies and their right-wing stalking horse, the Washington Legal Foundation, have been pushing for this move for years. They regard drug...
- News items 2009-08-07
- Invitrogen Promotes Mark Gardner to Chief Marketing Officer; Process Excellence and Marketing Expert to Expand Reach to Customers Through Broad Range of Channels
- CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN), a provider of essential life science technologies for disease research and drug discovery, today promoted Mark Gardner to Chief Marketing Officer for the company. In his new role, Gardner will lead the company's efforts in all areas of marketing, focusing on increasing the company's...
- Research articles 2005-05-04
- Boehringer Ingelheim and 8 Other Companies Caught Selling Illegal Painkillers
- The FDA has banned Boehringer Ingelheim and eight other drug companies from selling illegal, unapproved pain drugs. The drugs removed from the market include high concentrate morphine sulfate oral solutions, hydromorphone and oxycodone. The FDA: "Consumers have a right to expect that their drugs meet the...
- Blog posts 2009-04-01
- Radiant Research Names Kyle McAllister Vice President Business Development
- BELLEVUE, Wash. -- Radiant Research Inc., a comprehensive clinical research company that provides phase I-IV clinical drug development services to the biopharmaceutical industry, today announced that Kyle McAllister will join Radiant as Vice President of Business Development. McAllister will lead Radiant's specialized business development team directing the sales and marketing...
- Research articles 2005-02-15
- Advanced Viral Research Corp. Hires Public Relations Firm
- YONKERS, N.Y. -- Advanced Viral Research Corporation (OTCBB: ADVR), a research based biopharmaceutical company dedicated to anti-cancer drug discovery and development, announced today it has appointed the life sciences marketing communications firm The Signature Agency to assist in its overall branding and investor communications.
- Research articles 2007-06-01
- PhRMA Urged to Investigate Centocor's Marketing of Remicade
- To: NATIONAL EDITORSContact: Edgar Sandoval, +1-212-539-2940, +1-646-673-4102; or Matt Nerzig, +1-212-539-2882; both of SEIU Local 32BJ PHILADELPHIA, May 21 /PRNewswire-USNewswire/ -- Local 32BJ and several prominent health care professionals have written a letter asking PhRMA, the Pharmaceutical Research and Manufacturers of America, to investigate whether PhRMA member Johnson & Johnson's...
- Research articles 2007-05-21
- Pfizer - Neurontin: David Franklin and the private eye
- Did Pfizer, the world's largest pharmaceutical company, cross the line on the eve of last month's crucial test trial involving its controversial anti-seizure medication Neurontin?Two weeks after the trial abruptly ended with the plaintiffs agreeing to dismiss their case with prejudice, questions linger about why Pfizer sent a former CIA...
- News items 2009-08-10
- AstraZeneca rides Rx to success: packaging for the Anglo-Swedish drug giant focuses on information, patient-doctor relationship and compliance
- AstraZeneca's prescription for success is pretty basic: Make patient health the cornerstone of everything it does. The Anglo-Swedish pharmaceutical company is engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of health care services.
- Research articles 2005-12-01
- << Previous
- page 1 of 1
- Next >>
Presented by American Express